Thar Pharmaceuticals reinvents known, safe, on-the-market drugs by improving their clinical performance and economic benefits. We focus on transforming intravenous (IV) drugs into orally administered drugs, thus eliminating the cost of IV drug administration, a $34 billion annual worldwide healthcare cost paid by health systems, patients and insurers.
http://www.tharpharma.com/
Total raised: $4.3M
Investors 1
Date | Name | Website |
- | Innovation... | innovation... |
Funding Rounds 1
Date | Series | Amount | Investors |
- | - | $4.3M | - |
Mentions in press and media 5
Date | Title | Description | Source |
06.07.2012 | Drug reformulation company raising $2 million to advance can... | Thar’s strategy reflects the broader efforts by larger pharmaceutical companies to find new ways to ... | medcitynew... |
07.01.2011 | Drug reformulation firm Thar Pharmaceuticals raises $4.3M | The company will use the Series A to get it through Phase 2 trials of its lead product candidate, a ... | medcitynew... |
- | Pittsburgh’s Thar Pharmaceuticals raises $1.2M | PITTSBURGH, Pennsylvania — Thar Pharmaceuticals Inc. has raised $1.2 million in debt financing to co... | medcitynew... |
- | Drug reformulation company raising $2 million to advance can... | A pharmaceutical company reformulating intravenous drugs into orally administered medication is rais... | medcitynew... |
- | Drug reformulation firm Thar Pharmaceuticals raises $4.3M | Drug reformulation company Thar Pharmaceuticals has raised $4.3 million as part of a Series A invest... | medcitynew... |